Sign in

Jay Crandell

@jaycrandell.bsky.social
15 followers 30 following 0 posts

Studying antiviral immunity at Yale Immunobiology

PostsRepliesMedia
Reposted by Jay Crandell
Waggoner Lab @labwaggoner.bsky.social · 27/08/2025
Human monoclonal antibodies targeting A35 protect from death caused by monkeypox virus @cellcellpress.bsky.social @carolilucas.bsky.social @vivianasimonlab.bsky.social @mschotsaert.bsky.social www.cell.com/cell/fulltex...
185
Reposted by Jay Crandell
Carolina Lucas @carolilucas.bsky.social · 16/07/2025
Words matter. Scientific language shapes public perception and policy. Framing mpox as a disease of GBMSM may have reflected early patterns, but continuing this narrative misrepresents transmission risks and reinforces stigma. With Camila Coelho, Vries & Zucker 🌈 www.thelancet.com/journals/lan...
thelancet.com
A call to move beyond MSM-centric framing in mpox research
The resurgence of mpox poses urgent public health challenges, and the scientific community has mobilised admirably to understand its transmission, immunity, and therapeutics.1,2 However, the language ...
173
Reposted by Jay Crandell
The Lancet Microbe @lancetmicrobe.bsky.social · 28/04/2025
New research article The impact of #orthopoxvirus vaccination and #Mpox infection on cross-protective immunity: a multicohort observational study www.thelancet.com/journals/lan... #IDSky #ViroSky #ClinMicro #OpenAccess #OA
065
Reposted by Jay Crandell
Carolina Lucas @carolilucas.bsky.social · 28/04/2025
🚨 Our new study is live in The Lancet Microbe! “The impact of orthopoxvirus vaccination and Mpox infection on cross-protective immunity: a multicohort observational study” Led by @jaycrandell.bsky.social , Valter Monteiro and Lauren Pischel www.sciencedirect.com/science/arti... A thread 🧵!
sciencedirect.com
The impact of orthopoxvirus vaccination and Mpox infection on cross-protective immunity: a multicohort observational study
Cross-reactive immune memory responses to orthopoxviruses in humans remain poorly characterised despite their relevance for vaccine design and outbrea…
2199